We can't find the internet
Attempting to reconnect
18171.1 PFLS-LS
18171.1 PFLS-LS
Résumé
Lung-on-Chip for Pulmonary Fibrosis Compound Testing
Textes supplémentaires
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease with poor prognosis. Clinical evidence suggests that the mechanical strain induced by the respiration plays a key role in the progression of the disease. In contrast to current in-vivo and in-vitro models that poorly mimic key processes that take place in IPF, an advanced in-vitro model of the lung will be developed to test anti-fibrotic compounds.
Participants
Olivier Guenat
Wirtschaftspartner
olivier.guenat@alveolix.com
AlveoliX AG CHE-475.985.759 Olivier Guenat Murtenstrasse 50 3008 Bern BE CH
Olivier Guenat
Kontaktperson
olivier.guenat@artorg.unibe.ch
Universität Bern ARTORG Center Olivier Guenat Murtenstrasse 50 3008 Bern BE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2015-12-31
- Date de fin
- 2017-10-31
- Coûts totaux approuvés
- CHF 317552.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%